Evidence map›Paper›PMID 31219006›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Secondary Prophylaxis with Liposomal Amphotericin B in a Patient with Mucosal Leishmaniasis Undergoing Immunobiological Therapy for Active Ankylosing Spondylitis.

Antonio Carlos Nicodemo, Heitor Franco de Andrade, Pablo Muñoz Torres, Valdir Sabbaga Amato

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Ankylosing spondylitis coexisting withWorld journal of clinical cases · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antonio Carlos NicodemoDepartment of Infectious Diseases, University of São Paulo Medical School, Sao Paulo, Brazil.
Heitor Franco de AndradeDepartment of Pathology, University of São Paulo Medical School, Sao Paulo, Brazil.
Pablo Muñoz TorresDepartment of Infectious and Parasitic Diseases, Clinical Hospital, University of São Paulo Medical School, Sao Paulo, Brazil.
Valdir Sabbaga AmatoDepartment of Infectious Diseases, University of São Paulo Medical School, Sao Paulo, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosuppressive treatments for rheumatic diseases present special problems in areas endemic for chronic infectious diseases because of the possibility of reactivation. Leishmaniasis is a significant neglected tropical disease caused by different species of protozoan parasites within the genus

Indexed as

AdultAmphotericin BAntiprotozoal AgentsHumansImmunosuppressive AgentsImmunotherapyLeishmaniasis, MucocutaneousMaleRecurrenceSecondary PreventionSpondylitis, AnkylosingAmphotericin BAntiprotozoal AgentsImmunosuppressive Agentsliposomal amphotericin B

Identifiers

PMID31219006
PMCPMC6685582
OpenAlexW2950244681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.